Author's response to reviews Title: A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. Authors:

نویسندگان

  • Joe Gray
  • Dipankar Chattopadhyay
  • Gillian Patman
  • Luca Miele
  • Barry P King
  • Helen L Reeves
  • Kaichun Wu
چکیده

Joe Gray ([email protected]) Dipankar Chattopadhyay ([email protected]) Beale Gary ([email protected]) Gillian Patman ([email protected]) Luca Miele ([email protected]) Barry P King ([email protected]) Stewart Stephen ([email protected]) Hudson Mark ([email protected]) Christopher P Day ([email protected]) Derek Manas ([email protected]) Helen L Reeves ([email protected])

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی فراوانی کبد چرب با استفاده از سونوگرافی در دانش آموزان پسر بدون تاریخچه بیماری‌های کبدی و ارتباط آن با آنزیم های کبدی، شاخص توده بدنی و چربی دور کمر

Background: None Alcoholic Fatty Liver Disease (NAFLD) is the most common form of chronic liver disease and includes a wide range of clinical symptoms (from asymptomatic fatty liver to severe liver inflammation with fibrosis and even cirrhosis). Metabolic syndrome, obesity and type 2 diabetes, are major causes of NAFLD. As urban and sedentary lifestyle and poor diet lead to weight gain a...

متن کامل

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges

Non-alcoholic fatty liver disease (NAFLD) is emerging as a major health problem worldwide. NAFLD is a continuum of disease ranging from mild liver steatosis to severe steatohepatitis, which will ultimately lead to end-stage liver disease with high morbidity and mortality rates. This disorder is considered as a silent liver disease. The metabolic syndrome and its components are accounted as the ...

متن کامل

Assessment of the prevalence of non-alcoholic fatty liver disease in regular and non-regular blood and plasma donors

Abstract Background and Objectives Non-alcoholic liver disease (NAFLD) is a spectrum of diseases, ranging from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) which can lead to liver cirrhosis and hepatocellular carcinoma. Nonalchololic fatty liver  is the most prevalent hepatic disorder worldwide which can affect up to the one out of four adults. Little is known about...

متن کامل

A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach

  Background :Timely diagnosis of liver cirrhosis is vital for preventing further liver damage and giving the patient the chance of transplantation. Although biopsy of the liver is the gold standard for cirrhosis assessment, it has some risks and limitations and this has led to the development of new noninvasive methods to determine the stage and prognosis of the patients. We aimed to design an...

متن کامل

BINDING OF NAPROXEN TO SERUM PROTEINS IN PATIENTS WITH LIVER CIRRHOSIS AND HEALTHY INDIVIDUALS

A three-fold decrease of the in vitro ability of serum proteins to bind naproxen was shown in patients with cirrhosis of the liver compared to healthy individuals. This decrease was caused by quantitative changes in serum proteins in the sera of patients with liver damage. Lower doses of naproxen are therefore suggested in the treatment of patients with liver dysfunction.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009